{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T05:08:57Z","timestamp":1788930537606,"version":"build-2803163510"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Surg Today"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1007\/s00595-026-03377-y","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T17:28:34Z","timestamp":1782926914000},"page":"2447-2455","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Clinical impact of Kirsten rat sarcoma viral oncogene homolog (KRAS) mutation status on recurrence patterns and the efficacy of local therapy after hepatectomy for colorectal liver metastases"],"prefix":"10.1007","volume":"56","author":[{"given":"Kosuke","family":"Kanemitsu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiromitsu","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshiyuki","family":"Tagayasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Tanizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Ofuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Tajiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Kitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirohisa","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaaki","family":"Iwatsuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,7,1]]},"reference":[{"key":"3377_CR1","doi-asserted-by":"publisher","first-page":"1007","DOI":"10.1016\/S0140-6736(08)60455-9","volume":"371","author":"B Nordlinger","year":"2008","unstructured":"Nordlinger B, Sorbye H, Glimelius B, Poston GJ, Schlag PM, Rougier P, et al. Perioperative chemotherapy with FOLFOX4 and surgery versus surgery alone for resectable liver metastases from colorectal cancer (EORTC Intergroup trial 40983): a randomised controlled trial. Lancet. 2008;371:1007\u201316.","journal-title":"Lancet"},{"key":"3377_CR2","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1477-2574.2012.00557.x","volume":"15","author":"RB Adams","year":"2013","unstructured":"Adams RB, Aloia TA, Loyer E, Pawlik TM, Taouli B, Vauthey JN, Americas Hepato-Pancreato-Biliary A. Society of Surgical, O.; Society for Surgery of the Alimentary, T. Selection for hepatic resection of colorectal liver metastases: expert consensus statement. HPB (Oxford). 2013;15:91\u2013103.","journal-title":"HPB (Oxford)"},{"key":"3377_CR3","doi-asserted-by":"publisher","first-page":"318","DOI":"10.1002\/ags3.12628","volume":"7","author":"S Kasai","year":"2023","unstructured":"Kasai S, Ashida R, Sugiura T, Ohgi K, Yamada M, Otsuka S, et al. Long-term outcomes of staged liver resection for synchronous liver metastases from colorectal cancer and the clinical impact of early recurrence: A single-center retrospective cohort study. Ann Gastroenterol Surg. 2023;7:318\u201325.","journal-title":"Ann Gastroenterol Surg"},{"issue":"1","key":"3377_CR4","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/j.ccell.2017.12.004","volume":"33","author":"R Yaeger","year":"2018","unstructured":"Yaeger R, Chatila WK, Lipsyc MD, Hechtman JF, Cercek A, Sanchez-Vega F, et al. Clinical sequencing defines the genomic landscape of metastatic colorectal cancer. Cancer Cell. 2018;33(1):125\u2013e1363.","journal-title":"Cancer Cell"},{"key":"3377_CR5","doi-asserted-by":"publisher","first-page":"1746","DOI":"10.1093\/annonc\/mdw261","volume":"27","author":"DP Modest","year":"2016","unstructured":"Modest DP, Ricard I, Heinemann V, Hegewisch-Becker S, Schmiegel W, Porschen R, et al. Outcome according to KRAS-, NRAS- and BRAF-mutation as well as KRAS mutation variants: pooled analysis of five randomized trials in metastatic colorectal cancer by the AIO colorectal cancer study group. Ann Oncol. 2016;27:1746\u201353.","journal-title":"Ann Oncol"},{"issue":"5","key":"3377_CR6","doi-asserted-by":"publisher","first-page":"307","DOI":"10.1002\/gcc.20854","volume":"50","author":"CP Vaughn","year":"2011","unstructured":"Vaughn CP, Zobell SD, Furtado LV, Baker CL, Samowitz WS. Frequency of KRAS, BRAF, and NRAS mutations in colorectal cancer. Genes Chromosomes Cancer. 2011;50(5):307\u201312.","journal-title":"Genes Chromosomes Cancer"},{"key":"3377_CR7","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","volume":"6","author":"J Gao","year":"2013","unstructured":"Gao J, Aksoy BA, Dogrusoz U, Dresdner G, Gross B, Sumer SO, et al. Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal. Sci Signal. 2013;6:pl1.","journal-title":"Sci Signal"},{"key":"3377_CR8","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1016\/j.apsb.2019.03.002","volume":"9","author":"P Liu","year":"2019","unstructured":"Liu P, Wang Y, Li X. Targeting the untargetable KRAS in cancer therapy. Acta Pharm Sin B. 2019;9:871\u20139.","journal-title":"Acta Pharm Sin B"},{"key":"3377_CR9","doi-asserted-by":"publisher","first-page":"115","DOI":"10.1593\/neo.14184","volume":"16","author":"S Shukla","year":"2014","unstructured":"Shukla S, Allam US, Ahsan A, Chen G, Krishnamurthy PM, Marsh K, et al. KRAS protein stability is regulated through SMURF2: UBCH5 complex-mediated \u03b2-TrCP1 degradation. Neoplasia. 2014;16:115\u201328.","journal-title":"Neoplasia"},{"key":"3377_CR10","doi-asserted-by":"publisher","first-page":"2635","DOI":"10.1245\/s10434-016-5187-2","volume":"23","author":"KW Brudvik","year":"2016","unstructured":"Brudvik KW, Mise Y, Chung MH, Chun YS, Kopetz SE, Passot G, et al. RAS Mutation Predicts Positive Resection Margins and Narrower Resection Margins in Patients Undergoing Resection of Colorectal Liver Metastases. Ann Surg Oncol. 2016;23:2635\u201343.","journal-title":"Ann Surg Oncol"},{"key":"3377_CR11","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1002\/bjs.9870","volume":"102","author":"KW Brudvik","year":"2015","unstructured":"Brudvik KW, Kopetz SE, Li L, Conrad C, Aloia TA, Vauthey JN. Meta-analysis of KRAS mutations and survival after resection of colorectal liver metastases. Br J Surg. 2015;102:1175\u201383.","journal-title":"Br J Surg"},{"key":"3377_CR12","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1002\/jhbp.1389","volume":"31","author":"T Takematsu","year":"2024","unstructured":"Takematsu T, Mima K, Hayashi H, Kitano Y, Nakagawa S, Hiyoshi Y, et al. RAS mutation status in combination with the JSHBPS nomogram may be useful for preoperative identification of colorectal liver metastases with high risk of recurrence and mortality after hepatectomy. J Hepatobiliary Pancreat Sci. 2024;31:69\u201379.","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"3377_CR13","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1002\/ags3.12454","volume":"5","author":"MK Diener","year":"2021","unstructured":"Diener MK, Fichtner-Feigl S. Biomarkers in colorectal liver metastases: Rising complexity and unknown clinical significance? Ann Gastroenterol Surg. 2021;5:477\u201383.","journal-title":"Ann Gastroenterol Surg"},{"key":"3377_CR14","doi-asserted-by":"publisher","first-page":"4158","DOI":"10.1245\/s10434-015-4587-z","volume":"22","author":"GA Margonis","year":"2015","unstructured":"Margonis GA, Spolverato G, Kim Y, Karagkounis G, Choti MA, Pawlik TM. Effect of KRAS Mutation on Long-Term Outcomes of Patients Undergoing Hepatic Resection for Colorectal Liver Metastases. Ann Surg Oncol. 2015;22:4158\u201365.","journal-title":"Ann Surg Oncol"},{"key":"3377_CR15","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1186\/s12885-021-08144-5","volume":"21","author":"N Sakai","year":"2021","unstructured":"Sakai N, Furukawa K, Takayashiki T, Kuboki S, Takano S, Ohtsuka M. Differential effects of KRAS mutational status on long-term survival according to the timing of colorectal liver metastases. BMC Cancer. 2021;21:412.","journal-title":"BMC Cancer"},{"key":"3377_CR16","doi-asserted-by":"crossref","unstructured":"Rhaiem R, Rached L, Tashkandi A, Bouche O, Kianmanesh R. Implications of RAS Mutations on Oncological Outcomes of Surgical Resection and Thermal Ablation Techniques in the Treatment of Colorectal Liver Metastases. Cancers (Basel). 2022;14(3):816.","DOI":"10.3390\/cancers14030816"},{"key":"3377_CR17","doi-asserted-by":"crossref","unstructured":"Tajiri T, Mima K, Beppu T, Hayashi H, Horino T, Adachi Y et al. RAS-Beppu Classification: A New Recurrence Risk Classification System Incorporating the Beppu Score and RAS Status for Colorectal Liver Metastases. Cancers (Basel). 2025;17(4):640.","DOI":"10.3390\/cancers17040640"},{"key":"3377_CR18","doi-asserted-by":"publisher","first-page":"895","DOI":"10.1002\/jso.70021","volume":"132","author":"T Beppu","year":"2025","unstructured":"Beppu T, Masuda T, Miyata T, Imai K, Hayashi H. The Growing Potential of Thermal Ablation for Colorectal Liver Metastases. J Surg Oncol. 2025;132:895\u2013907.","journal-title":"J Surg Oncol"},{"key":"3377_CR19","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1158\/1078-0432.CCR-10-1720","volume":"17","author":"J Tie","year":"2011","unstructured":"Tie J, Lipton L, Desai J, Gibbs P, Jorissen RN, Christie M, et al. KRAS mutation is associated with lung metastasis in patients with curatively resected colorectal cancer. Clin Cancer Res. 2011;17:1122\u201330.","journal-title":"Clin Cancer Res"},{"key":"3377_CR20","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1007\/s00595-024-02900-3","volume":"55","author":"K Chen","year":"2025","unstructured":"Chen K, Okamura Y, Hatakeyama K, Shiomi A, Kagawa H, Hino A, et al. The KRAS G12D mutation increases the risk of unresectable recurrence of resectable colorectal liver-only metastasis. Surg Today. 2025;55:273\u201382.","journal-title":"Surg Today"},{"key":"3377_CR21","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s00595-024-02920-z","volume":"55","author":"M Ninomiya","year":"2025","unstructured":"Ninomiya M, Itoh S, Takeishi K, Toshima T, Yoshiya S, Morita K, et al. Proposal of borderline resectable colorectal liver metastases based on analysis of risk factors for early surgical failure. Surg Today. 2025;55:425\u201333.","journal-title":"Surg Today"},{"key":"3377_CR22","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1002\/ags3.12689","volume":"7","author":"H Maki","year":"2023","unstructured":"Maki H, Jain AJ, Haddad A, Lendoire M, Chun YS, Vauthey JN. Locoregional treatment for colorectal liver metastases aiming for precision medicine. Ann Gastroenterol Surg. 2023;7:543\u201352.","journal-title":"Ann Gastroenterol Surg"},{"key":"3377_CR23","doi-asserted-by":"crossref","unstructured":"Masuda T, Beppu T, Okabe H, Imai K, Hayashi H. How Can We Improve the Survival of Patients with Colorectal Liver Metastases Using Thermal Ablation? Cancers (Basel). 2025;17(2):199.","DOI":"10.3390\/cancers17020199"},{"issue":"3","key":"3377_CR24","doi-asserted-by":"publisher","first-page":"486","DOI":"10.21037\/hbsn-2025-197","volume":"14","author":"R Rhaiem","year":"2025","unstructured":"Rhaiem R, Cauchy F, Faron M, Sa Cunha A, Farges O. Thermal Ablation in the Curative Treatment of Colorectal Liver Metastasis: New Standard of Care? \u2014 Lessons Learned from the COLLISION Trial. Hepatobiliary Surg Nutr. 2025;14(3):486\u20139.","journal-title":"Hepatobiliary Surg Nutr"},{"key":"3377_CR25","doi-asserted-by":"publisher","first-page":"814","DOI":"10.1002\/ags3.12917","volume":"9","author":"T Uotani","year":"2025","unstructured":"Uotani T, Takamoto T, Nara S, Ban D, Mizui T, Moritani K, et al. Impact of primary tumor clinicopathological factors on prognosis after hepatic resection for rectal liver metastases. Ann Gastroenterol Surg. 2025;9:814\u201321.","journal-title":"Ann Gastroenterol Surg"}],"container-title":["Surgery Today"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03377-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00595-026-03377-y","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00595-026-03377-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T04:35:58Z","timestamp":1788928558000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00595-026-03377-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,7,1]]},"references-count":25,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["3377"],"URL":"https:\/\/doi.org\/10.1007\/s00595-026-03377-y","relation":{},"ISSN":["0941-1291","1436-2813"],"issn-type":[{"value":"0941-1291","type":"print"},{"value":"1436-2813","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,7,1]]},"assertion":[{"value":"16 April 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 July 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"We have no conflicts of interest, financial or otherwise, to declare.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Approval of the research protocol: The protocol of this study was approved by the human ethics review committee of the Graduate School of Medicine, Kumamoto University, and carried out according to the Declaration of Helsinki and Good Clinical Practice Guidelines.","order":2,"name":"Ethics","label":"Ethics Statement","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":3,"name":"Ethics","label":"Informed Consent","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":4,"name":"Ethics","label":"Registry and the Registration No. of the study\/trial","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"N\/A.","order":5,"name":"Ethics","label":"Animal Studies","group":{"name":"EthicsHeading","label":"Declarations"}}]}}